Research & Treatment Development for FXTAS

Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is a rare neurological disease that can display Ataxia as a symptom.

The National Ataxia Foundation is proud to host this webinar presented by Dr. David Hessl on September 23rd, 2024. In "Research & Treatment Development for FXTAS", he gave an overview of how it is studied and gave an overview of the current state of research and drug development for the disease.

For more information on Ataxia, please visit our website: https://www.ataxia.org

Become a Free NAF member! https://bit.ly/JoinNAF

Follow us on Social Media!
NAF Facebook:   / ataxiafounda.  .
NAF Twitter:   / naf_ataxia  
NAF Instagram:   / ataxiafound.  .
Ataxia Subreddit:   / ataxia  

About the Speaker-

Dr. David Hessl is a clinical psychologist offering assessment, treatment recommendations and consultation to individuals with neurodevelopmental disorders. He has special clinical interest and expertise in fragile X-associated disorders, autism, ADHD, Down syndrome and intellectual disability.

Dr. Hessl directs the Translational Psychophysiology and Assessment Laboratory (T-PAL) at the UC Davis MIND Institute to investigate the emotional psychophysiology of children with neurodevelopmental disorders, and to develop novel outcome measures for clinical trials. He also conducts collaborative studies with other researchers, investigating brain imaging, molecular genetics and neuropsychology in an effort to understand links between genetics, brain function and behavior. His research focus is primarily on fragile X-associated disorders, such as fragile X syndrome and fragile X-associated tremor ataxia syndrome (FXTAS). His lab has contributed to the refinement or development of cognitive and behavioral assessments for people with disabilities